CSF p-Tau levels in the prediction of Alzheimer's disease. - Wikidata - awgldk - TriplyDB

CSF p-Tau levels in the prediction of Alzheimer's disease.

CSF p-Tau levels in the prediction of Alzheimer's disease.

http://www.wikidata.org/entity/Q41845685

about

Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images.Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers Proteome-wide characterization of signalling interactions in the hippocampal CA4/DG subfield of patients with Alzheimer's disease.Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients.Exogenous expression of Drp1 plays neuroprotective roles in the Alzheimer's disease in the Aβ42 transgenic Drosophila model.Alzheimer's Biomarkers are Correlated with Brain Connectivity in Older Adults Differentially during Resting and Task States.Cross-View Neuroimage Pattern Analysis in Alzheimer's Disease Staging.Abnormal Changes of Brain Cortical Anatomy and the Association with Plasma MicroRNA107 Level in Amnestic Mild Cognitive Impairment.A Surgical Method to Improve the Homeostasis of CSF for the Treatment of Alzheimer's Disease.Amyloid Plaques in Retina for Diagnosis in Alzheimer's Patients: a Meta-Analysis.Regularized Linear Discriminant Analysis of EEG Features in Dementia Patients.Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer's Disease.Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.Tangled tau: Active pathology or footprint of disease?Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.

P2860

Q33701135-E7AF77D0-E344-4AAF-9A5E-AB2709B7B7C2 Q34468797-1436DFE6-5A3E-465F-8C80-23A72ED7620C Q35713134-1C2D559E-24D5-403A-9A35-6D0A66B68CDF Q36086092-6196AED0-D1F3-4E09-91A0-874637BACEEA Q36377666-349E6480-AFD4-4B30-B2DA-36F88EBEB071 Q36554846-9C0636F0-9963-4B7F-AD6B-099D40D8140E Q36606287-DF16B074-2E99-4D33-9501-70482A86663B Q36911784-983D16C2-B3C5-42E2-8CB6-3C4EE830C533 Q37385649-53E195B0-238A-4D74-BEF9-08F7528480D2 Q37405016-B18E496B-F6B6-4106-AE53-36DA155D1078 Q37452576-345E339B-0D76-4DB2-BCAA-8A75D5DAA023 Q37588576-D2A87872-183F-4B83-9CD7-ACCF78613052 Q37627051-CFD5AC6B-DD84-4230-B22B-A88BCED364FF Q38855547-F052530C-6EAB-4E35-88CC-43454016B4F9 Q44937365-15B28FBD-C9CB-46DC-A541-ED851AD0104B Q47153644-09C9D128-0C36-46CE-8BFB-00385832097E Q48319851-E382DC88-E750-41F1-BC68-F149FB1378B5

P2860

CSF p-Tau levels in the prediction of Alzheimer's disease.

http://www.wikidata.org/entity/Q41845685

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

CSF p-Tau levels in the prediction of Alzheimer's disease.

@en

type

label

CSF p-Tau levels in the prediction of Alzheimer's disease.

@en

prefLabel

CSF p-Tau levels in the prediction of Alzheimer's disease.

@en

P1433

Q41845685-855E9698-FCB2-415C-8770-C5BFB5E5E506

P1476

Q41845685-E449004C-5E28-4F39-BEF0-B647A92621A6

P2093

Q41845685-0937FB26-2D66-484A-A999-66A8CEF5F5FB

Q41845685-2B0A0138-3E28-4A37-B996-5FA20D88CA04

Q41845685-3E22F111-4743-4267-9BAF-9609A49D0F2E

Q41845685-417E27FB-9B29-411A-9A72-DCBE93551994

Q41845685-4AD538F5-45F7-4DEE-89AD-1078508CBB95

Q41845685-579F56D4-2AE3-4120-87E1-E937A6D0D414

Q41845685-BA6864EF-5C40-4E8C-907F-44B1F1E5ADBB

Q41845685-C94FF6D7-B3CD-4A7F-B5EF-6BB2F6CDBB30

Q41845685-F5E3FB20-07D0-4D58-9917-8BD0F4FA0A8D

P2860

Q41845685-01120A05-9DD6-4A50-8086-20BE1941EFD3

Q41845685-1048BB30-D5B4-487F-B5E2-9F217B0ECAF1

Q41845685-17F023A3-CDD8-477F-A0BB-00F2650B166A

Q41845685-1B172C8D-1FAF-4FA9-9667-9E30D2F9A3AF

Q41845685-2377AD0F-1994-4180-9C68-4220528184C3

Q41845685-24481FC1-4E07-4615-AD7A-2E45AE0B96B5

Q41845685-2631775D-303F-40CB-A4E1-4341110CC62B

Q41845685-2B6C94CA-F343-4130-9B32-46B0576F6A84

Q41845685-2B9B9CF6-6B14-4365-9071-7918ADF2F662

Q41845685-2E5006FA-AEF2-4108-AB05-A737AB9B389A

P304

Q41845685-0E758AD9-47E3-4E3F-8312-CFC697BEC55A

P31

Q41845685-CE972CC6-7EB2-4F67-A8F9-D52D19D8E642

P356

Q41845685-5C08336C-573D-4636-98B1-ABBD9600BDE8

P433

Q41845685-B6855719-9F40-44B6-8437-18ECBBBB53CE

P478

Q41845685-B82C20F4-2313-415F-A4BD-6C471B35D942

P50

Q41845685-00E15B6B-643B-4290-BB11-89C00946E657

P577

Q41845685-90AA31D9-A923-41EE-826D-D9D260F25382

P5875

Q41845685-2C226534-9B9B-413D-ABCE-B3DC98EFF80D

P698

Q41845685-EDA37039-C9E5-4C9B-9501-10FC638AA172

P921

Q41845685-5A721253-19F1-4DEB-8D6F-966F40FF3F31

P932

Q41845685-CC33B410-1A73-49BD-A488-AA90297E51C0

P356

P1433

P1476

CSF p-Tau levels in the prediction of Alzheimer's disease

@en

P2093

Alka Kaushal

http://www.w3.org/2001/XMLSchema#string

Deep Raj Sharma

http://www.w3.org/2001/XMLSchema#string

Kajal Jain

http://www.w3.org/2001/XMLSchema#string

Kiran Dip Gill

http://www.w3.org/2001/XMLSchema#string

Neerja Bhardwaj

http://www.w3.org/2001/XMLSchema#string

Nidhi Gupta

http://www.w3.org/2001/XMLSchema#string

Sudesh Prabhakar

http://www.w3.org/2001/XMLSchema#string

V K Grover

http://www.w3.org/2001/XMLSchema#string

Willayat Yousuf Wani

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature.

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau.

Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein.

CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.

Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay.

Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies.

siRNA against presenilin 1 (PS1) down regulates amyloid β42 production in IMR-32 cells.

P304

1119-1124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1242/BIO.20135447

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Ramesh Kandimalla

P577

2013-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258639853

http://www.w3.org/2001/XMLSchema#string

P698

24244848

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3828758

http://www.w3.org/2001/XMLSchema#string